Unmet medical need
The market for percutaneous femoral access and vascular closure devices has grown significantly since they were first launched in the early 1990's and is based on a wide range of technologies. While some of the newer closure devices can be used in what was considered to be patients at high risk such as those with PAD (Peripheral Arterial Disease) and smaller caliber arteries, the CardioDex device can be used in all types of patients and situations, including bifurcations, PAD, SFA (superficial femoral arterial) punctures as well as in very thin or obese patients. Whatever the anatomic challenge, the CardioDex device has consistently shown outstanding efficacy, short time to ambulation and reliable closures free of residual materials.
Professor Charles Davidson, Clinical Chief, Cardiology Medical Director, Bluhm Cardiovascular Institute Northwestern Memorial Hospital and CardioDex's Chief medical officer states that: "Thermal closure of the arterial puncture site has several potential advantages including nothing left behind and the ability to address challenging anatomies. The initial successful cases we have had demonstrate the promise of this new technology".
CardioDex (http://www.cardiodex.com) was founded by one of the most renowned medical entrepreneurs in the health and aesthetic medicine arena, Dr. Shimon Eckhouse, a scientist with broad experience in medical devices and medical technology.
CardioDex, Ltd. develops and manufactures an innovative disposable solution for the clo
|SOURCE CardioDex Ltd.|
Copyright©2010 PR Newswire.
All rights reserved